1. The potential of EGCG in modulating the oral-gut axis microbiota for treating inflammatory bowel disease
   Jiaming Ge et al, 2024, Phytomedicine CrossRef
2. Biochanin A inhibits endothelial dysfunction induced by IL‑6‑stimulated endothelial microparticles in Perthes disease via the NFκB pathway
   Jianhong Liu et al, 2024, Experimental and Therapeutic Medicine CrossRef
3. Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition
   Sejin Kim et al, 2023, Antioxidants CrossRef
4. Protective effect of green tea and epigallocatechin-3-gallate in a LPS-induced systemic inflammation model
   Juliana Hofstätter Azambuja et al, 2022, The Journal of Nutritional Biochemistry CrossRef
5. Epigallocatechin-3-gallate protects sepsis‐induced myocardial dysfunction by inhibiting the nuclear factor-κB signaling pathway
   Bei Chen et al, 2024, Heliyon CrossRef
6. Analysis of the role and mechanism of EGCG in septic cardiomyopathy based on network pharmacology
   Ji Wu et al, 2022, PeerJ CrossRef
7. Vincamine, an active constituent of Vinca rosea ameliorates experimentally induced acute lung injury in Swiss albino mice through modulation of Nrf-2/NF-κB signaling cascade
   Akshata Patangrao Renushe et al, 2022, International Immunopharmacology CrossRef
8. Chemico-biological aspects of (−)- epigallocatechin- 3 -gallate (EGCG) to improve its stability, bioavailability and membrane permeability: Current status and future prospects
   Revathy Sahadevan et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef